Now showing items 1-4 of 4

    • Formulation and evaluation of niosomes-based chlorpheniramine gel for the treatment of mild to moderate skin allergy 

      Afreen, Urooj; Fahelelbom, Khairi Mustafa; Shah, Syed Nisar Hussain; Ashames, Akram; Almas, Uzma; Khan, Shujaat Ali; Yameen, Muhammad Arfat; Nisar, Naveed; Bin Asad, Muhammad Hassham Hassan; Murtaza, Ghulam (Taylor and Francis Ltd., 2022)
      Purpose of present study was to develop eight formulations of chlorpheniramine (CPM) niosomes according to 23 factorial design, characterise on the basis of various evaluation tests, i.e. in vitro drug release, SEM, FTIR, ...
    • Nanostructured lipid carriers based suppository for enhanced rectal absorption of ondansetron: In vitro and in vivo evaluations 

      Alotaibi, Badriyah Shadid; Pervaiz, Fahad; Buabeid, Manal; Ashames, Akram; Fahelelbom, Khairi Mustafa; Siddique, Sana; Shoukat, Hina; Rehman, Sadia; Noreen, Sobia; Murtaza, Ghulam (Elsevier B.V., 2021)
      The current research aimed to fabricate ondansetron nanostructured lipid carriers (OND-NLCs) and incorporate them into a suppository base to manage chemotherapy-induced vomiting and nausea, which offer the advantage of ...
    • Nurses perception of pharmaceutical care practice: A qualitative approach 

      Kharaba, Zelal; Kousar, Rozina; Alfoteih, Yassen; Azhar, Saira; Khan, Shujaat Ali; Murtaza, Ghulam (University of Benin, 2020)
      Purpose: To evaluate the perception of nurses regarding pharmaceutical care services in the healthcare system of Khyber Pakhtunkhwa (KPK) Province of Pakistan. Methods: This qualitative study was implemented by conducting ...
    • Potential strategies for combating COVID-19 

      Shamim, Saba; Khan, Maryam; Kharaba, Zelal Jaber; Ijaz, Munazza; Murtaza, Ghulam (Springer, 2020)
      Coronavirus disease 2019, also known as COVID-19, is caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. The infection has now catapulted into a full-blown pandemic across ...